GSK Pharma parent makes open offer

Mint 2018-02-16

Views 3

GlaxoSmithKline made an open offer to buy back as 20.61 million shares of publicly traded GlaxmSmithKline Pharmaceuticals, valuing the purchase at Rs6,400 crore. Mint's Malvika Joshi has more details.
Show more

Share This Video


Download

  
Report form
RELATED VIDEOS
Etihad Airways trying to avoid open offer
play
02:11

Etihad Airways trying to avoid open offer
Sun Pharma-Ranbaxy deal in CCI crosshairs
play
02:41

Sun Pharma-Ranbaxy deal in CCI crosshairs
Sun Pharma acquires Ranbaxy Labs
play
07:44

Sun Pharma acquires Ranbaxy Labs
Pharma companies versus trade association
play
01:49

Pharma companies versus trade association
Reporter's Notebook | Pharma sector slows down in March quarter
play
00:57

Reporter's Notebook | Pharma sector slows down in March quarter
Reporter's Notebook | Sun Pharma eyes Swedish drug maker Meda
play
02:15

Reporter's Notebook | Sun Pharma eyes Swedish drug maker Meda
Sun Pharma posts loss, Cipla gains from exports
play
01:07

Sun Pharma posts loss, Cipla gains from exports
Will DGCI ban on drug ingredients from China hurt the Pharma industry?
play
03:25

Will DGCI ban on drug ingredients from China hurt the Pharma industry?
Pharma stocks crash after new NPPA rule
play
01:29

Pharma stocks crash after new NPPA rule
CSO of Biologics at Glenmark Pharma: On India strategy | Q&A
play
01:59

CSO of Biologics at Glenmark Pharma: On India strategy | Q&A
From the Newsroom| Pharma sector in 2013
play
03:19

From the Newsroom| Pharma sector in 2013
Pharma industry to post 15% growth in profit
play
03:12

Pharma industry to post 15% growth in profit